Laurel Wealth Advisors (North Carolina)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
26,205
+25,830
| +6,888% | +$370K | 0.01% | 367 |
|
|
2025
Q1 | $27.6K | Hold |
375
| – | – | ﹤0.01% | 375 |
|
|
2024
Q4 | $24.6K | Sell |
375
-45
| -11% | -$2.95K | ﹤0.01% | 394 |
|
|
2024
Q3 | $32.7K | Buy |
420
+45
| +12% | +$3.51K | 0.01% | 350 |
|
|
2024
Q2 | $29.2K | Hold |
375
| – | – | 0.01% | 339 |
|
|
2024
Q1 | $25.4K | Hold |
375
| – | – | ﹤0.01% | 363 |
|
|
2023
Q4 | $25.3K | Hold |
375
| – | – | ﹤0.01% | 342 |
|
|
2023
Q3 | $25.4K | Hold |
375
| – | – | 0.01% | 341 |
|
|
2023
Q2 | $26.8K | Sell |
375
-375
| -50% | -$26.8K | 0.01% | 338 |
|
|
2023
Q1 | $52.1K | Buy |
750
+375
| +100% | +$26K | 0.01% | 275 |
|
|
2022
Q4 | $25.4K | Hold |
375
| – | – | 0.01% | 313 |
|
|
2022
Q3 | $21K | Hold |
375
| – | – | 0.01% | 326 |
|
|
2022
Q2 | $25K | Hold |
375
| – | – | 0.01% | 315 |
|
|
2022
Q1 | $25K | Hold |
375
| – | – | 0.01% | 321 |
|
|
2021
Q4 | $22K | Hold |
375
| – | – | ﹤0.01% | 331 |
|
|
2021
Q3 | $23K | Hold |
375
| – | – | 0.01% | 327 |
|
|
2021
Q2 | $22K | Hold |
375
| – | – | ﹤0.01% | 366 |
|
|
2021
Q1 | $19K | Hold |
375
| – | – | ﹤0.01% | 354 |
|
|
2020
Q4 | $19K | Hold |
375
| – | – | ﹤0.01% | 352 |
|
|
2020
Q3 | $21K | Hold |
375
| – | – | 0.01% | 307 |
|
|
2020
Q2 | $20K | Buy |
+375
| New | +$20K | 0.01% | 310 |
|